Carbocistein (CAS 638-23-3): Comprehensive Product Guide
Table of Contents
1. Product Overview & Specifications
Carbocistein (CAS 638-23-3) is a mucolytic agent used to reduce mucus viscosity in respiratory conditions. Below are key specifications:
| Parameter | Details |
|---|---|
| Chemical Name | S-Carboxymethylcysteine |
| CAS Number | 638-23-3 |
| Molecular Formula | C5H9NO4S |
| Molecular Weight | 179.19 g/mol |
| Appearance | White crystalline powder |
| Solubility | Soluble in water, slightly soluble in ethanol |
| Purity | ≥98% (HPLC) |
| Storage | 2-8°C in airtight containers |
Comparative Analysis with Similar Agents
| Feature | Carbocistein | Acetylcysteine | Bromhexine |
|---|---|---|---|
| Mechanism | Mucoregulation | Direct mucolysis | Secretolytic |
| Side Effects | Low | Moderate | High |
| Indications | Chronic bronchitis, COPD | Acute mucus plugs | Bronchitis |
| Dosage Form | Oral, syrup | Inhalation, oral | Oral |
2. Applications of Carbocistein
Medical Uses
- Chronic Respiratory Diseases: Reduces mucus viscosity in COPD, asthma, and cystic fibrosis.
- Otolaryngology: Treats sinusitis and otitis media with effusion.
- Post-Surgical Care: Prevents mucus accumulation post-thoracic surgery.
Non-Medical Uses
- Veterinary Medicine: Manages respiratory infections in livestock.
- Research: Studied for anti-inflammatory properties in preclinical models.
3. Usage Guidelines & Safety
Recommended Dosage
- Adults: 750-1500 mg/day in divided doses.
- Children: 20-30 mg/kg/day (under medical supervision).
Contraindications
- Peptic ulcer disease.
- Hypersensitivity to carbocistein derivatives.
Drug Interactions
- Avoid concurrent use with antitussives.
- Monitor with antibiotic therapies.
4. Industry Research & Procurement Insights
Market Drivers
- Rising prevalence of respiratory disorders.
- Increased geriatric population requiring mucolytics.
Procurement Factors
- Verify GMP compliance and COA.
- Assess supplier lead times and bulk discounts.
5. Client Case Studies
Case 1: Pharmaceutical Manufacturer (Germany)
- Challenge: Develop a pediatric syrup for chronic bronchitis.
- Solution: Sourced high-purity carbocistein for stable formulation.
- Result: 30% faster mucus clearance in clinical trials.
Case 2: Veterinary Clinic (USA)
- Challenge: Treat equine respiratory infections.
- Solution: Administered carbocistein oral granules.
- Result: 50% reduction in recovery time.
6. Contact for Quotations
Request a quote or technical dossier:
- Email: info@vivalr.com
- Phone: (86) 15866781826



评论
目前还没有评论。